6533b86dfe1ef96bd12c9d4a
RESEARCH PRODUCT
O-7 FOLFIRI ± napabucasin in patients with previously treated metastatic colorectal cancer: Overall survival results from the phase 3 CanStem303C study
Matthew HitronChristina WuV. ChiuSang Cheul OhAndrés CervantesJulien TaiebR. XuBo XuJohanna C. BendellAxel GrotheyE. Van CutsemMarwan FakihNiall C. TebbuttTakayuki YoshinoJ. TaberneroManish A. ShahAlfredo FalconeMarilyn FontaineKensei YamaguchiJiri Tomaseksubject
Oncologymedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseaseOncologyInternal medicineOverall survivalmedicineFOLFIRIIn patientPreviously treatedbusinessNapabucasinyear | journal | country | edition | language |
---|---|---|---|---|
2021-07-01 | Annals of Oncology |